Skip to content
411 PRESS
WarningRecall #D-0221-2026Drug / Pharmaceutical

Fagron Compounding Services Recalls Tropicamide 1%/Cyclopentolate 1%/Phenylephrine

Fagron Compounding Services · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01

Reason for Recall

Incorrect Product Formulation

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

U.S. Nationwide.

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Fagron Compounding Services initiated the recall on November 20, 2025 affecting 2980 syringes. Incorrect Product Formulation. The product was distributed in U.S. Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Fagron Compounding Services for further instructions.

Independent news on labor, safety, and accountability.